Gilead Sciences, Inc.
MCL1 INHIBITORS
Last updated:
Abstract:
The present disclosure generally relates to compounds of Formula (I) and pharmaceutical compositions that may be used in methods of treating cancer. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
10 Nov 2020
Issue date:
10 Jun 2021